This site is intended for heath plan professionals in Canada.
This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
All NIHB Plan Members Ages 2 Years and Older
Managing their Type 1 and Type 2 Diabetes with Insulin
are Eligible for Dexcom G6 Coverage
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada – Journal of Comparative Effectiveness Research– September 5, 2023
Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada – Diabetes– June 20, 2023
Cost-effectiveness of Real-Time Continuous Glucose Monitoring – CanadaCGM – October 2022
Cost Offset Analysis (COA) Comparing RT-CGM With SMBG in People With Type 1 Diabetes in Eight Countries – ATTD – 2020
Long-term Cost-Effectiveness of Dexcom G6 Continuous Glucose Monitor in Canada – www.capt-actp.ca – 2020🍁
Dexcom G6 for real-time continuous glucose monitoring – www.nice.org.uk – 2020